112 related articles for article (PubMed ID: 7667224)
21. Currently available antimicrobial agents and their potential for use as monotherapy.
Peterson LR
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():30-45. PubMed ID: 19040464
[TBL] [Abstract][Full Text] [Related]
22. [Penetration and intracellular activity of fluoroquinolones].
Pascual A; García I
Enferm Infecc Microbiol Clin; 1998 Mar; 16(3):138-43. PubMed ID: 9611878
[No Abstract] [Full Text] [Related]
23. Revisiting "older" antimicrobials in the era of multidrug resistance.
Pogue JM; Marchaim D; Kaye D; Kaye KS
Pharmacotherapy; 2011 Sep; 31(9):912-21. PubMed ID: 21923592
[TBL] [Abstract][Full Text] [Related]
24. Professional phagocytes: predators and prey of microorganisms.
Krause KH
Schweiz Med Wochenschr; 2000 Jan; 130(4):97-100. PubMed ID: 10780050
[TBL] [Abstract][Full Text] [Related]
25. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
Siporin C
Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
[TBL] [Abstract][Full Text] [Related]
26. Next-generation precision antimicrobials: towards personalized treatment of infectious diseases.
de la Fuente-Nunez C; Torres MD; Mojica FJ; Lu TK
Curr Opin Microbiol; 2017 Jun; 37():95-102. PubMed ID: 28623720
[TBL] [Abstract][Full Text] [Related]
27. Incentives for developing new antibiotics or antimicrobial strategies.
Dahle UR; Petersen FC
BMJ; 2013 Apr; 346():f2136. PubMed ID: 23568793
[No Abstract] [Full Text] [Related]
28. Antimicrobial drug interactions in the critically ill patients.
Pereira JM; Paiva JA
Curr Clin Pharmacol; 2013 Feb; 8(1):25-38. PubMed ID: 22946870
[TBL] [Abstract][Full Text] [Related]
29. Thioridazine: resurrection as an antimicrobial agent?
Thanacoody HK
Br J Clin Pharmacol; 2007 Nov; 64(5):566-74. PubMed ID: 17764469
[TBL] [Abstract][Full Text] [Related]
30. The quinolones: decades of development and use.
Emmerson AM; Jones AM
J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699
[TBL] [Abstract][Full Text] [Related]
31. Plasmonic nano-antimicrobials: properties, mechanisms and applications in microbe inactivation and sensing.
An X; Erramilli S; Reinhard BM
Nanoscale; 2021 Feb; 13(6):3374-3411. PubMed ID: 33538743
[TBL] [Abstract][Full Text] [Related]
32. The chemistry and applications of antimicrobial polymers: a state-of-the-art review.
Kenawy el-R; Worley SD; Broughton R
Biomacromolecules; 2007 May; 8(5):1359-84. PubMed ID: 17425365
[TBL] [Abstract][Full Text] [Related]
33. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
Sato K; Tomioka H
Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
[TBL] [Abstract][Full Text] [Related]
34. Using combination therapy to thwart drug resistance.
Hill JA; Cowen LE
Future Microbiol; 2015; 10(11):1719-26. PubMed ID: 26597425
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial effectiveness of bioactive packaging materials from edible chitosan and casein polymers: assessment on carrot, cheese, and salami.
Moreira Mdel R; Pereda M; Marcovich NE; Roura SI
J Food Sci; 2011; 76(1):M54-63. PubMed ID: 21535694
[TBL] [Abstract][Full Text] [Related]
36. Peptides as the next generation of anti-infectives.
Mercer DK; O'Neil DA
Future Med Chem; 2013 Mar; 5(3):315-37. PubMed ID: 23464521
[TBL] [Abstract][Full Text] [Related]
37. Novel anti-infectives: is host defence the answer?
Hamill P; Brown K; Jenssen H; Hancock RE
Curr Opin Biotechnol; 2008 Dec; 19(6):628-36. PubMed ID: 19000763
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Varghese JM; Roberts JA; Lipman J
Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings.
Diazgranados CA; Cardo DM; McGowan JE
Int J Antimicrob Agents; 2008 Jul; 32(1):1-9. PubMed ID: 18550343
[TBL] [Abstract][Full Text] [Related]
40. Interactions between antimicrobial drugs and phagocytes: an overview.
Labro MT
Int J Antimicrob Agents; 1993; 3(2):73-87. PubMed ID: 18611547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
